IPECC-Instituto de Pesquisa Clínica de Campinas

Campinas, São Paulo 13060-080

0 studies enrolling now · 2 studies all time

What they study most

COVID, COVID-19, Cardiovascular Diseases, Cardiovascular Risk Factor

Studies at this site

• Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors — Stopped early
• Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation — Completed